TipRanks
Arcturus Therapeutics (ARCT)
NASDAQ:ARCT
US Market
ARCT
Arcturus Therapeutics
RESEARCH TOOLSreports
Want to see ARCT full AI Analyst Report?

Arcturus Therapeutics (ARCT) Stock News & Sentiment

2,166 Followers
Editas, Sagimet, Dropbox, Arcturus, Quanta Trending With Analysts
Premium
Weekend Updates
Editas, Sagimet, Dropbox, Arcturus, Quanta Trending With Analysts
12d ago
DBX
PWR
Analyst Maintains Hold on Arcturus as Early LUNAR 2.0 Promise Balances ARCT-810 Uncertainties; $9 Price Target Reaffirmed
Premium
Ratings
Analyst Maintains Hold on Arcturus as Early LUNAR 2.0 Promise Balances ARCT-810 Uncertainties; $9 Price Target Reaffirmed
14d ago
ARCT
Arcturus Showcases Phase 2 ARCT-810 Data, mRNA Advances
Premium
Company Announcements
Arcturus Showcases Phase 2 ARCT-810 Data, mRNA Advances
15d ago
8K
ARCT
Arcturus Therapeutics Highlights ARCT-810 Progress at Metabolic Symposium
Premium
Company Announcements
Arcturus Therapeutics Highlights ARCT-810 Progress at Metabolic Symposium
1M ago
8K
ARCT
Arcturus Therapeutics Earnings Call Balances Progress, Pressure
Premium
Company Announcements
Arcturus Therapeutics Earnings Call Balances Progress, Pressure
2M ago
ARCT
Arcturus Maintained at Buy as Advancing Pipeline and Strong Cash Position Support Unchanged $23 Price Target
Premium
Ratings
Arcturus Maintained at Buy as Advancing Pipeline and Strong Cash Position Support Unchanged $23 Price Target
2M ago
ARCT
ARCT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
ARCT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
ARCT
More ARCT News >

ARCT News on the Web

Editas, Sagimet, Dropbox, Arcturus, Quanta Trending With Analysts
TipRanks News
Bullish
Analyst Maintains Hold on Arcturus as Early LUNAR 2.0 Promise Balances ARCT-810 Uncertainties; $9 Price Target Reaffirmed
TipRanks News
Neutral
Arcturus Therapeutics upgraded to Buy from Neutral at Citi
TipRanks News
Bullish
Arcturus Therapeutics Holdings Inc to Host Virtual Presentation Transcript
GuruFocus News
Neutral
Arcturus Showcases Phase 2 ARCT-810 Data, mRNA Advances
TipRanks News
Neutral
Arcturus Therapeutics to acquire myNEO
TipRanks News
Bullish
Arcturus Therapeutics announces interim OTC deficiency Phase 2 results
TipRanks News
Bullish
Arcturus Therapeutics Holdings Inc at Citi Biopharma Back to School Summit Transcript
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
ARCT
Sector Average
Media Buzz
This Week2 articles
Weekly Average4.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ARCT’s Media Buzz Sentiment?
2 articles about ARCT were published this week. In an average week, 4.75 articles are published.
    What is ARCT’s weekly average amount of articles?
    In an average week, 4.75 articles about ARCT are published.
      What is ARCT’s News Sentiment?
      100% of articles about ARCT were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        XENEXenon
        ABTAbbott Laboratories
        BBIOBridgeBio Pharma
        BDXBecton Dickinson
        NVSNovartis
        Showing the stocks with the most bullish news sentiment over the past week